期刊文献+

重构型天冬氨酸特异性半胱氨酸蛋白酶3表达载体诱导人肺腺癌细胞凋亡的意义 被引量:4

Construction of reversed caspase-3 and it′s effect on apoptosis induction in human lung adenocarcinoma cell line A549
原文传递
导出
摘要 目的构建天冬氨酸特异性半胱氨酸蛋白酶3(Caspase3)表达载体,观察Caspase3表达载体对人肺腺癌A549细胞凋亡的影响。方法应用基因重组方法,建立重构型Caspase3基因的真核表达系统pcDNA3.1revCaspase3质粒和野生型pcDNA3.1Caspase3质粒。将实验细胞分为3组转染pcDNA3.1revCaspase3质粒组,转染pcDNA3.1Caspase3质粒组,转染pcDNA3.1质粒空白对照组。前2组用Caspase3抑制剂DEVDfmk干预。应用Caspase3酶活性分析、流式细胞仪及甲基偶氮唑蓝(MTT)比色法检测A549细胞Caspase3酶活性变化及细胞凋亡和增殖情况。结果(1)pcDNA3.1revCaspase3质粒组、pcDNA3.1Caspase3质粒组的A549细胞Caspase3酶活性分别是(11.87±0.92)%、(5.34±0.38)%(t=16.02,P<0.01);用Caspase3抑制剂DEVDfmk干预后,pcDNA3.1revCaspase3质粒组酶活性为(7.04±0.48)%,仍明显高于野生型pcDNA3.1Caspase3质粒组的(4.51±0.20)%(t=11.86,P<0.01)。(2)流式细胞分析结果显示,pcDNA3.1revCaspase3质粒组、pcDNA3.1Caspase3质粒组和pcDNA3.1质粒组的A549细胞凋亡率分别是(20.1±3.5)%、(7.8±2.8)%、(1.4±0.3)%,3组差异有统计学意义(F=44.01,P<0.01)。(3)MTT比色检测显示pcDNA3.1revCaspase3质粒组、pcDNA3.1Caspase3质粒组和pcDNA3.1质粒组的A549细胞生存率分别是(35.7±1.1)%、(72.8±2.9)%、(85.4±4.8)%,转染pcDNA3.1revCaspase3质粒组生存率明显低于其他两组(F=375.07,P<0.01)。结论pcDNA3.1revCaspase3在A549细胞内有较强的自身活化能力,对Caspase3抑制剂抵抗作用较强,可明显诱导A549细胞凋亡并抑制A549细胞生长。 Objective To investigate the effect of reversed caspase-3 expression vector on apoptosis of human lung adenocarcinoma cell line A549. Methods Reversed pcDNA 3. 1-rev-caspase-3 plasmid and wild type pcDNA3. 1-caspase-3 plasmid were constructed by genetic recombination. Three experiments (groups) with A549 cells were carried out: a group of transfection with pcDNA 3. 1-rev-caspase plasmid, a group of transfection with pcDNA 3.1-caspase plasmid, and a control group of transfection with pcDNA 3.1 plasmid. Intervention with DEVD-fmk, an inhibitor of caspase-3, was carried out in the first two groups. The activity of caspase-3, the apoptosis and the growth of A549 cells were measured. Results ( 1 ) The activity of caspase-3 in the pcDNA 3. 1-rev-caspase-3 plasmid group and pcDNA 3.1-caspase-3 plasmid group was ( 11.87 ±0. 92) % and ( 5.34 ± 0. 38 ) % , respectively, significantly higher in the former group (t = 16.02, P 〈 0.01 ). After intervention with DEVD-fmk, the activity of caspase-3 in pcDNA 3.1-rev-caspase-3 plasmid group and in pcDNA 3.1-caspase-3 plasmid group was (7.04 ± 0.48 )% and (4. 51 ± 0. 20) % , respectively, also significantly higher in the former group ( t = 11.86, P 〈 0. 01 ). ( 2 ) Flow cytometry showed that the apoptosis rate of A549 cells in pcDNA 3.1-rev-caspase-3 plasmid group, pcDNA 3.1-caspase-3 plasmid group and pcDNA 3. 1 plasmid group was ( 20. 1 ± 3.5 ) % , ( 7.8 ± 2. 8 ) % and ( 1.4 ± 0.3 ) % , respectively. The difference of the apoptosis rate was significant ( F = 44. 01, P 〈 0. 01 ). (3) The survival rates of A549 cells in the pcDNA 3.1-rev-caspase-3 plasmid group, pcDNA 3.1-caspase-3 plasmidgroup and pcDNA 3.1 plasmid group were (35.7 ± 1.1)%, (72.8±2.9)% and (85.4 ± 4. 8) % , respectively. The survival rate of A549 cells in peDNA 3.1-rev-easpase-3 plasmid group was lower than those in the other two groups ( F = 375.07, P 〈 0. 01 ). Coneltmions pcDNA 3.1-rev-caspase-3 in A549 cells has a strong activity and can resist caspese-3 inhibitor in A549 cells. It can also induce A549 cell apoptosis and inhibit the growth of A549 cells.
出处 《中华结核和呼吸杂志》 CAS CSCD 北大核心 2005年第8期537-540,共4页 Chinese Journal of Tuberculosis and Respiratory Diseases
基金 湖南省自然科学基金资助项目(03JJY4036)
  • 相关文献

参考文献8

  • 1卢晓晔,覃莉,黄中新,黄丹.Caspase活化的细胞凋亡在非小细胞肺癌组织中的表达[J].实用癌症杂志,2002,17(2):122-124. 被引量:8
  • 2Yamabe K, Shimizu S, Ito T, et al. Cancer gene therapy using a pro-apoptotic gene, Caspase-3, Gene Ther, 1999, 12 : 1952-1959.
  • 3Srinivasula SM, Ahmad M, MacFarlane M, et al. Generation of constitutively active recombinant caspases-3 and -6 by rearrangement of their subunits. J Biol Chems, 1998, 273. 10107-10111.
  • 4李艳芳,王旭东,梁永钜,陈黎明,丁岩,黄民,符立梧.三氧化二砷通过线粒体依赖性通路诱导喉癌细胞株及其耐药株细胞凋亡[J].癌症,2004,23(6):631-634. 被引量:13
  • 5Shinoura N, Muramatsu Y, Yoshida Y, et al. Adenovirus-mediated tranfer of Caspase-3 with Fas ligand induces drastic apoptosis in U-373MG glima cells. Exp Cell Res, 2000, 256:423-433.
  • 6Maccorkle RA, Freeman KW, Spencer DM. Synthetic activation of caspase: artificial death switches. Proc Natl Acad Sci USA, 1998,95 : 3655-3660.
  • 7Colussi PA, Harvey NL, Shearwin-Whyatt LM, et al. Conversion of proCaspase-3 to an autoactivating caspase by fusion to the caspase-2 prodomain. J Biol Chem, 1998,273 : 26566-26570.
  • 8Komata T, Kondo Y, Kanzawa T, et al. Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptuse), gene promoter. Cancer Res, 2001, 61:5796-5802.

二级参考文献17

  • 1Fu LW, Deng ZA, Pan QC, et al. Screening and discovery novel potent the multidrug resistant modulators from naturally occurring bisbenzylisoquinoline alkaloids [J]. Anticancer Res, 2001, (4):2273 - 2280.
  • 2Matsuda T, Suzuki Y, Tanioka Y, et al. Pancreas preservation by the 2-layer cold storage method before islet isolation protects isolated islets against apoptosis through the mitochondrial pathway [ J ]. Surgery, 2003, 134 (3): 437 - 445.
  • 3Amarante-Mendes GP, Naekyung Kim C, Lin L, et al. Bcr-Abl Exerts Its Antiapoptotic Effect Against Diverse Apoptotic Stimuli Through Blockage of Mitochondrial Release of Cytochrome C and Activation of Caspase-3 [J]. Blood, 1998, 91 (5): 1700 - 1705.
  • 4Kim CN, Wang X, Huang Y, et al. Overexpression of Bcl-xL inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis [J]. CancerRes, 1997,57(15):3115-3120.
  • 5Decaudin D, Geley S, Hirsch T, et al. Bcl-2 and Bcl-xL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents [J]. Cancer Res, 1997, 57(1): 62 -67.
  • 6Beauparlant P, Shore GC. Therapeutic activation of caspases in cancer: a question of selectivity [J] . Curr Opin Drug Discov Devel, 2003, 6(2): 179 - 187.
  • 7Jaattela M. Programmed cell death: many ways for cells to die decently [J]. Ann Med, 2002, 34(6):480 -488.
  • 8Ruefli AA, Smyth MJ, Johnstone RW. HMBA induces activation of a caspase-independent cell death pathway to overcome Pglycoprotein-mediated multidrug resistance [J], Blood, 2000, 95(7): 2378 - 85.
  • 9Smyth MJ, Krasovskis E, Sutton VR, et al. The drug efflux protein,P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis [J]. Proc Natl Acad Sci USA, 1998, 95(12): 7024-7029.
  • 10Morisaki T, Katano M. Mitochondria-targeting therapeutic strategies for overcoming chemoresistance and progression of cancer [J]. Curr Med Chem, 2003, 10(23): 2517 -2521.

共引文献19

同被引文献30

  • 1杨义军,朱捷,付汉江,孙志贤,郑晓飞.hTERT启动子调控caspase3基因的特异性表达及其抑癌作用[J].军事医学科学院院刊,2005,29(2):116-119. 被引量:1
  • 2WIRTH T, KUHNEL F, KUBICKA S. Telomerase-de pendent gene therapy[J]. Curr Mol Med, 2005, 5(2):243- 251.
  • 3PAINTER R G, LANSON N A, JIN Z, et al. Conditional expression of a suicide gene by the telomere reverse transcriptase promoter for potential post-therapeutic deletion of tumorigenesis[J]. Cancer Sci, 2005, 96(9):607-613.
  • 4KOMATA T, KONDO Y, KANAZAWA T, et al. Caspase- 8 gene therapy using the human telomerase reverse transcriptase promoter for malignant glioma cells[J]. Hum Gene Ther, 2002, 13(9) :1015-1025.
  • 5JACOB D, DAVIS J J, ZHANG L, et al. Suppression of pancreatic tumor growth in the liver by systemic administration of the TRAIL gene driven by the hTERT promoter[J]. Cancer Gene Ther, 2005, 12(2) :109-115.
  • 6YANG L F, ZHAO Y, CAO Y, et al. hTERT/re-caspase-3 system induce apoptosis in hTERT-positive cancer cells[J]. Cancer Biol Ther, 2006, 5(11):1546-1553.
  • 7KYO S, TAKAKURA M, TAIRA T, et al. Spl cooperates with c-myc to activate transcription of the human telomerase reverse transcriptase gene(hTERT) [J]. Nucleic Acids Res, 2000, 28(3) :669-677.
  • 8LI H, XU D, LI J, et al. Transforming growth factor beta suppresses human telomerase reverse transcriptase(hTERT) by Smad3 interactions with c-Myc and the hTERT gene[J]. J Biol Chem, 2006, 281(35):25588-25600.
  • 9SCHRADE M, BURGER A M, MULLER M, et al. The differentiation status of primary gonadal germ cell tumors correlates inversely with telomerase activity and the expression level of the gene encoding the catalytic subunit of telomerase[J]. BMCCancer, 2002, 7(2):32-36.
  • 10MEILER J, SCHULER M. Therapeutic targeting of apoptotic pathways in eancer[J]. Curr Drug Targets, 2006, 7 (10) : 1361-1369.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部